The EndoGoddess App launched in September 2011 as a work in progress. As of today, the unique points reward feature is present but the ability for users to cash those points in for iTunes downloads has not yet been updated in the app store.
The EndoGoddess App is one of several entrepreneural products that have been produced by mobile software startup Duet Health (formerly named Eproximiti). Otherwise, we at Duet Health have been making proprietary products for healthcare companies and hospitals. Happily, those clients have been growing. However, that means that time for coding and updates is diverted to making products for clients until the entrepreneural products, like the EndoGoddess App, receive more investment funding to pay for the time that it will take to finish the necessary software updates as well as finishing the building of the exciting app accessory features which are currently only partially built (meter connectivity, CGMS connectivity, EMR connectivity, prescription renewal, patient portal).
Since the launch of the EndoGoddess app, the growth of new users has slowed down some. I believe that the lack of noted iTunes software update has likely slowed growth. Interested investors have said that there need to be more users before they will invest. However, time is money and thus time spent for EndoGoddess App updates takes away from Duet Health's proprietary revenue. Thus, as in the diagram above, the EndoGoddess App is stalled right before the 'release of improvement'.
Determination and hard work are two things that I know well from medical school and medical training. So, the pursuit of more EndoGoddess App funding is my new target. I know 100% that the EndoGoddess App is a GREAT product for patients and an engaging tool that endocrinologists can happily recommend to their patients to motivate their glucose checking behaviors and to improve their health outcomes, especially for teens. Thus, you can bet that I will be chasing after as many opportunites and reward challenges and accelerators that exist. Stay tuned! :)